BioSpace News Archive

Genetic testing has become an important medical standard for families with known histories of hereditary disease. Individuals who choose to go through the mental and emotional process of taking a genetic test and absorbing the potentially life-changing conclusions may be disturbed to find out that results of such tests are not always consistent.

Joint studies will evaluate one or more of Pfizer’s investigational NASH therapies in combination with Novartis’s FXR agonist for the treatment of the progressive liver disease

EBD Group (‘EBD’), the market-leading provider of world-class partnering events and tools for the global life science industry, has opened its newly updated partneringONE® platform for BIO-Europe® 2018, Europe’s largest life science partnering conference, following a successful trial at the recent BioPharm America™ conference.

MYR Pharma today announced that the results of 48 weeks of administration of Myrcludex, MYR`s first-in-class entry inhibitor for treatment of hepatitis B and D infection, will be presented at the Presidential Plenary Session of the upcoming AASLD meeting in San Francisco

“REKOOP” is the first Bedding solution to use Applied DNA’s CertainT Platform and Reliance Industries’ Recron GreenGold fiber for source verification and traceability of recycled polyester across the supply chain; Arrives in US Q1 2019

Co-Diagnostics, Inc. announced today that it will be offering a presentation of its mosquito vector control program at the 71st Annual Utah Mosquito Abatement Association conference in Ogden, Utah on October 29, 2018.

NeoTract today announced the company received the Phoenix 2018 Emerging Growth Company Award at the 25th Annual Phoenix Medical Device and Diagnostic Conference.

REKOVELLE® helps women achieve a more predictable and targeted ovarian response

Mario Gomez MD PA is now offering cutting-edge laser hair removal treatments for men and women in the greater Homestead area using the Astanza ReSmooth diode laser. Dr. Gomez is a leading obstetrician-gynecologist (OBGYN) who specializes in women’s health.

Anixa Biosciences today announced that it will present data from its ongoing studies utilizing Cchek™, Anixa’s artificial intelligence (AI) driven early cancer detection technology.